Imperative Care Launches Innovative Dual-Catheter System for Stroke Treatment

Imperative Care, a leading medical device company, has unveiled a groundbreaking approach to stroke treatment with the launch of its Zoom DuoPort system. This innovative technology combines two catheters to provide uninterrupted aspiration during thrombectomy procedures, potentially revolutionizing the way clinicians remove blood clots in stroke patients.

Dual-Catheter Approach Enhances Clot Removal Efficiency

The Zoom DuoPort system introduces a novel technique called continuous dual aspiration technique (CDAT), which connects two catheters to a single vacuum source. This approach addresses a critical challenge in stroke treatment: the difficulty of fully ingesting larger clots with a single, narrower catheter.

Imperative Care's method involves placing a narrower Zoom catheter within its large-bore, 0.88-inch system. This combination allows for more effective clot capture and removal, as the clot can be pulled back into the wider opening for complete extraction from the body.

Clinical Trial Results and Time-to-Treatment Improvements

Ariel Sutton, general manager of Imperative Care's stroke business, highlighted the success of the CDAT approach in clinical trials. Patients treated with dual aspiration showed a median time of just 19 minutes from the initial incision to the restoration of blood flow to the target tissue. This significant reduction in treatment time could have profound implications for stroke outcomes, as faster treatment is often associated with better patient recovery.

FDA Clearance and System Evolution

The launch of the Zoom DuoPort system follows the FDA's clearance earlier this year of Imperative Care's large-bore catheter for removing oxygen-blocking blood clots. This clearance paved the way for the development of the CDAT approach, which was refined based on feedback from physicians participating in the Imperative Trial.

Sutton emphasized the company's commitment to innovation, stating, "We have introduced a full-system approach, starting with arch access and .088" intracranial access, through complete clot ingestion with asymmetric aspiration. Now, the CDAT approach allows physicians to achieve the benefits of our full system using dual aspiration."